Cargando…

Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine

The rapid growth of the global HIV/AIDS epidemic makes it a high priority to develop an effective vaccine. Since a live attenuated or inactivated HIV vaccine is not likely to be approved for clinical application due to safety concerns, HIV virus like particles (VLPs) offer an attractive alternative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, XiZhen, Wang, XiaoDan, Zhao, DongHai, Meng, XiangYu, Zhao, XingHong, Yu, XiangHui, Kong, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2011
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089044/ https://www.ncbi.nlm.nih.gov/pubmed/22173311 http://dx.doi.org/10.1007/s11427-011-4244-0

Ejemplares similares

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity
por: Chan, Jo-Anne, et al.
Publicado: (2019)

Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger
por: Jiao, Cuicui, et al.
Publicado: (2020)

Epitope Tags beside the N-Terminal Cytoplasmic Tail of Human BST-2 Alter Its Intracellular Trafficking and HIV-1 Restriction
por: Lv, Mingyu, et al.
Publicado: (2014)

Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles
por: Cheng, Lin-Feng, et al.
Publicado: (2016)

Canine Parvovirus VP2 Protein Expressed in Silkworm Pupae Self-Assembles into Virus-Like Particles with High Immunogenicity
por: Feng, Hao, et al.
Publicado: (2014)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus
por: Wu, Xuan, et al.
Publicado: (2019)

Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice
por: Zhao, Hui, et al.
Publicado: (2015)

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
por: Gonelli, Christopher A., et al.
Publicado: (2021)

Antigenicity and immunogenicity of chikungunya virus-like particles from mosquito cells
por: Tsai, Shan-Ko, et al.
Publicado: (2022)

Vaccine with bacterium‐like particles displaying HIV‐1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques
por: Wang, Huaiyu, et al.
Publicado: (2022)

Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer’s disease
por: Fu, Lu, et al.
Publicado: (2017)

Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
por: Gunter, Cornelius J., et al.
Publicado: (2019)

Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development
por: Zhao, Yiwen, et al.
Publicado: (2022)

Immunogenicity of a Recombinant Measles-HIV-1 Clade B Candidate Vaccine
por: Stebbings, Richard, et al.
Publicado: (2012)

Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis
por: Choi, Won Hyung, et al.
Publicado: (2020)

Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein
por: Zhou, Yong-Fei, et al.
Publicado: (2022)

Polarity Changes in the Transmembrane Domain Core of HIV-1 Vpu Inhibits Its Anti-Tetherin Activity
por: Lv, Mingyu, et al.
Publicado: (2011)

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
por: Jeoung, Hye-Young, et al.
Publicado: (2011)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
por: Nooraei, Saghi, et al.
Publicado: (2021)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
por: Chapman, Rosamund, et al.
Publicado: (2020)

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
por: Vasan, Sandhya, et al.
Publicado: (2011)

Immunogenicity Assessment of Rift Valley Fever Virus Virus-Like Particles in BALB/c Mice
por: Li, Yuetao, et al.
Publicado: (2020)

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
por: Zhang, Xiao, et al.
Publicado: (2020)

Transcriptome analysis of Brassica napus pod using RNA-Seq and identification of lipid-related candidate genes
por: Xu, Hai-Ming, et al.
Publicado: (2015)

Construction and Immunogenicity Comparison of Three Virus-Like Particles Carrying Different Combinations of Structural Proteins of Avian Coronavirus Infectious Bronchitis Virus
por: Zhang, Yu, et al.
Publicado: (2021)

Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtration
por: Park, Young Chan, et al.
Publicado: (2017)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Construction of Porcine Epidemic Diarrhea Virus-Like Particles and Its Immunogenicity in Mice
por: Kim, Jihee, et al.
Publicado: (2021)

Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
por: Chauveau, Lise, et al.
Publicado: (2021)

Immunogenicity of a DNA vaccine candidate for COVID-19
por: Smith, Trevor R. F., et al.
Publicado: (2020)

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
por: Pillet, Stéphane, et al.
Publicado: (2022)

Development of candidate HIV vaccines using VSV vectors to express membrane-anchored MPER immunogen
por: Yuan, M, et al.
Publicado: (2012)

Ovine rotavirus strain LLR-85-based bovine rotavirus candidate vaccines: Construction, characterization and immunogenicity evaluation
por: Chang, Ji-Tao, et al.
Publicado: (2010)

Expression of FMD virus-like particles in yeast Hansenula polymorpha and immunogenicity of combine with CpG and aluminum adjuvant
por: Zhang, Jianhui, et al.
Publicado: (2023)

Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
por: Torrents de la Peña, Alba, et al.
Publicado: (2017)

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
por: Liu, Yan, et al.
Publicado: (2014)

2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age
por: Masuda, Taisei, et al.
Publicado: (2018)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
por: Collins, Katharine A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qie2q563bmln2bgumikkej7thb